GREECE - Lamda acquires 20% stake in Alapis for EUR 90m

The share issue is estimated to raise a total of EUR 451.1m.

Athens based Alapis specialises in the manufacturing and distribution of pharmaceuticals and parapharmaceutical products, veterinary pharmaceuticals, cosmetics and detergents. The company also distributes small animal accessories, medical equipment and health equipment products. It is expected to report a EUR 1.2bn turnover with a EUR 300m EBITDA in 2009.

The capital increase will go to the repayment of short-term debt, as well as finance expected working capital requirements. It will also enable Alapis to pursue targeted acquisitions of companies and other assets, in order to further support its growth strategy in the Greek and South-Eastern European healthcare markets.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Southern Europe